Ferrara JL - Search Results

1

EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, Shaw BE, Flowers ME, Ruutu T, Greinix H, Holler E, Basak G, Duarte RF, Pavletic SZ; EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the “EBMT−NIH (National Institutes of Health)−CIBMTR (Center for International Blood and Marrow Transplant Research) GvHD Task Force”. Schoemans HM, et al. Among authors: ferrara jl. Bone Marrow Transplant. 2018 Nov;53(11):1401-1415. doi: 10.1038/s41409-018-0204-7. Epub 2018 Jun 5. Bone Marrow Transplant. 2018. PMID: 29872128 Free PMC article.

2

Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation.

Ferrara JL. Ferrara JL. Bone Marrow Transplant. 1992;10 Suppl 1:10-2. Bone Marrow Transplant. 1992. PMID: 1387830 Review. No abstract available.

3

Nuclear magnetic resonance of hepatic graft-versus-host disease in mice.

Blatter DD, Crawford JM, Ferrara JL. Blatter DD, et al. Among authors: ferrara jl. Transplantation. 1990 Dec;50(6):1011-8. doi: 10.1097/00007890-199012000-00023. Transplantation. 1990. PMID: 2256143

4

Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens.

Krenger W, Snyder K, Smith S, Ferrara JL. Krenger W, et al. Among authors: ferrara jl. Transplantation. 1994 Dec 15;58(11):1251-7. Transplantation. 1994. PMID: 7992370

5

Paradigm shift for graft-versus-host disease.

Ferrara JL. Ferrara JL. Bone Marrow Transplant. 1994 Aug;14(2):183-4. Bone Marrow Transplant. 1994. PMID: 7994229 No abstract available.

6

Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens.

Abhyankar S, Gilliland DG, Ferrara JL. Abhyankar S, et al. Among authors: ferrara jl. Transplantation. 1993 Dec;56(6):1518-23. doi: 10.1097/00007890-199312000-00045. Transplantation. 1993. PMID: 8279027

7

Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.

Ferrara JL, Abhyankar S, Gilliland DG. Ferrara JL, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1216-7. Transplant Proc. 1993. PMID: 8442093 No abstract available.

8

Cytokine inhibitors and graft-versus-host disease.

Ferrara JL. Ferrara JL. Ann N Y Acad Sci. 1995 Dec 29;770:227-36. doi: 10.1111/j.1749-6632.1995.tb31058.x. Ann N Y Acad Sci. 1995. PMID: 8597363 Review.

9

Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease.

Krenger W, Cooke KR, Crawford JM, Sonis ST, Simmons R, Pan L, Delmonte J Jr, Karandikar M, Ferrara JL. Krenger W, et al. Among authors: ferrara jl. Transplantation. 1996 Nov 15;62(9):1278-85. doi: 10.1097/00007890-199611150-00018. Transplantation. 1996. PMID: 8932272

10

Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.

Porter DL, Roth MS, Lee SJ, McGarigle C, Ferrara JL, Antin JH. Porter DL, et al. Among authors: ferrara jl. Bone Marrow Transplant. 1996 Nov;18(5):975-80. Bone Marrow Transplant. 1996. PMID: 8932854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters